论文部分内容阅读
目的观察依达拉奉治疗大脑中动脉脑梗死的临床疗效。方法将128例大脑中动脉脑梗死患者随机分为2组。对照组64例给予磷酸川芎嗪氯化钠注射液静脉滴注,治疗组64例在对照组的基础上同时给予依达拉奉静脉滴注。结果 2组治疗后HSS评分均高于治疗前,且治疗组HSS评分高于对照组;治疗组的总有效率(95%)明显高于对照组(72%)。结论依达拉奉治疗大脑中动脉脑梗死疗效显著。
Objective To observe the clinical efficacy of edaravone in the treatment of middle cerebral artery occlusion. Methods 128 cases of middle cerebral artery infarction were randomly divided into two groups. Sixty-four patients in the control group were given intravenous infusion of Ligustrazine and Sodium Chloride Injection, and 64 in the treatment group were given intravenous edaravone intravenously on the basis of the control group. Results The HSS scores of two groups were higher than those before treatment, and the HSS scores of the treatment group were higher than those of the control group. The total effective rate (95%) of the treatment group was significantly higher than that of the control group (72%). Conclusion Edaravone has a significant therapeutic effect on middle cerebral artery occlusion.